Folger Hill Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Folger Hill Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-451,869	Closed	-$2.1M	–	320
2017 Q2	$2.1M	Hold	451,869	–	–	0.19%	112
2017 Q1	$2.24M	Buy	451,869 +62,283	+16%	+$599K	0.18%	145
2016 Q4	$4.32M	Sell	389,586 -123,409	-24%	-$1.16M	0.39%	92
2016 Q3	$4.75M	Buy	512,995 +275,000	+116%	+$2.3M	0.28%	113
2016 Q2	$1.51M	Hold	237,995	–	–	0.12%	142
2016 Q1	$1.55M	Hold	237,995	–	–	0.09%	137
2015 Q4	$1.93M	Buy	+237,995	New	+$1.78M	0.12%	148

Other funds holding FOMX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Folger Hill Asset Management's FOMX Position: Q3 2017 in Review

Folger Hill Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2017, closing a stake of 451,869 shares — an estimated $2.1M sold.

Folger Hill Asset Management first reported a position in FOMX in Q4 2015 and held it in 7 quarters. The position peaked at $4.75M in Q3 2016. 45 funds tracked by Wall St. Rank hold FOMX as of Q3 2017.

Folger Hill Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Folger Hill Asset Management sold 451,869 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2017, an estimated $2.1M.
Folger Hill Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2015 and held it in 7 quarters.
Folger Hill Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $4.75M in Q3 2016.
45 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.